ARS Pharmaceuticals, Inc. - Common Stock SPRY 深 沪
等待开盘 11-29 09:30:00 美东时间
4.815
+0.135
+2.88%
华盛通- 最 高4.89
- 今 开4.67
- 成交量 44.65万股
- 最 低 4.6525
- 昨 收 4.68
- 总市值 4.60亿
- 52周最高 9.65
- 市盈率 静 --
- 换手率 0.47%
- 52周最低 2.55
- 委 比 40.50%
- 总股本 9556.83万
- 历史最高 63.41
- 量 比 1.05
- 振 幅 5.07%
- 历史最低 2.55
- 每 手 1
- 风险率 1.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股丨思科斥巨资收购！Splunk隔夜涨超20%；LIFW周四飙升55%
思科宣布以280亿美元现金收购网络安全软件公司Splunk；健康保险理赔公司MSP Recovery隔夜股票交易量异常放大，成交超1亿美元；抗癌药物制造商隔夜涨超12%>>
09-22 18:29
What's Going On With ARS Pharmaceuticals Stock Today?
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares are trading higher Thursday. The move marks a rebound in the stock following a recent drop in price.
09-22 03:02
Wedbush Maintains Outperform on ARS Pharmaceuticals, Lowers Price Target to $5
Wedbush analyst Andreas Argyrides maintains ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform and lowers the price target from $15 to $5.
09-21 21:31
Gold Moves Higher; Fed Leaves Key Overnight Interest Rate Unchanged
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 200 points on Wednesday. The Dow traded up 0.59% to 34,720.69 while the NASDAQ fell 0.07% to 13,668.37. The S&P 500 also rose, gaining, 0.17% to 4,451.42.
09-21 02:33
Nasdaq Turns Lower; Cambridge Bancorp Shares Surge
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Wednesday. The Dow traded up 0.56% to 34,711.50 while the NASDAQ fell 0.17% to 13,654.54. The S&P 500 also rose, gaining, 0.21% to 4,453.12.
09-21 00:09
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
Upgrades For Regency Centers Corp (NASDAQ:REG), Argus Research upgraded the pre...
09-20 23:00
Dow Gains 150 Points; General Mills Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 150 points on Tuesday. The Dow traded up 0.47% to 34,680.84 while the NASDAQ rose 0.26% to 13,713.13. The S&P 500 also rose, gaining, 0.37% to 4,460.20.
09-20 22:22
FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray
The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type I), including anaphylaxis (fatal allergic reaction) for
09-20 21:21
Sell Instacart Now, Uber, Cisco And EPAM Systems: CNBC's 'Final Trades'
Joshua Brown of Ritholtz Wealth Management recommends selling shares of Instacart (Maplebear Inc.) (NYSE: CART), which just went public.
09-20 20:57
Market-Moving News for September 20th
EXAI: 36% | Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany SPRY: -66% | FDA Issues Complete Response Letter For ARS Pharma's neffy® Epinephrine Nasal
09-20 20:34
